Shawnee Weir
Endocrinology, Diabetes & Metabolism · Raleigh, NCNPI 1245208529
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $689 and has fallen 97.3% since, to $18 in 2024. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in NC, where the typical reported total is $1,143.
Across 112 payments — averaging $14.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mannkind Corporation$289
- Xeris Pharmaceuticals, Inc.$195
- Johnson & Johnson$181
- Novo Nordisk$179
- Lilly USA, LLC$158
- Abbott$114
- plus $477 from 17 others
What the payments were for
- Food & beverage$1,55598%
- Education$392%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mannkind Corporation | 29 | $289 |
| Xeris Pharmaceuticals, Inc. | 10 | $195 |
| Johnson & Johnson | 18 | $181 |
| Novo Nordisk | 14 | $179 |
| Lilly USA, LLC | 8 | $158 |
| Abbott | 2 | $114 |
| IBSA Pharma Inc. | 4 | $60 |
| Amgen(2 entities) | 4 | $54 |
| Boehringer Ingelheim | 3 | $45 |
| AbbVie | 3 | $43 |
| Dexcom, Inc. | 2 | $32 |
| Gilead | 1 | $31 |
| Acella Pharmaceuticals, LLC | 2 | $29 |
| Senseonics, Incorporated | 1 | $27 |
| AstraZeneca | 2 | $25 |
| Ascendis Pharma Endocrinology Inc | 1 | $23 |
| Companion Medical, Inc. | 2 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Insulet Corporation | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Medtronic | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$1,593 in reported general payments places this provider in the 50th percentile of 232 endocrinology, diabetes & metabolism providers in North Carolina.
See all endocrinology, diabetes & metabolism providers in North Carolina →
Other endocrinology, diabetes & metabolism in Raleigh
- Corey BerlinRaleigh$742K
- Denis BeckerRaleigh$459K
- Elizabeth HoltRaleigh$167K
- Julia Warren-UlanchRaleigh$31K
- Bhairavi SheshadriRaleigh$28K
- Glenn StallRaleigh$9K
- Mark WarrenGreenville$915K
- Thomas OconnellBurlington$805K
- Michael FavoritoWilmington$723K
- Stephen SouthGreensboro$624K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.